Bayer HealthCare Pharmaceuticals Inc. offers VistaTrak, a contrast media management system that provides a new management tool designed to help enhance patient care and safety, optimize inventory management and improve billing accuracy.

VistaTrak is a collaboration between Bayer HealthCare Pharmaceuticals and Mobile Aspects, a provider of Radio Frequency Identification (RFID)-enabled solutions for healthcare and hospital environments. The companies worked together to optimize Mobile Aspects’ proprietary iRIS platform for clinical environments that use contrast media. Bayer is the first company to offer a contrast media management system based on an RFID platform to automate manual processes and capture valuable operational data that currently cannot be found in any one system.

The system combines RFID technology of “tagged” bottles of contrast agent with a “smart” cabinet and a specially designed interface to capture, store and manage product utilization data easily and reliably while helping to reduce the risk of human error. It provides solutions for the use of contrast media, such as:
• Facilitating patient safety by automatically screening data from a patient’s electronic medical record (EMR) for, among other things, contraindications and prior adverse events
• Capturing information stored on the tag, such as NDC number, expiration date and lot number, automatically and in an efficient manner that supports compliance with accrediting organization requirements
• Providing contrast dosing information to improve billing accuracy and help address any existing issues with reimbursement or audits
• Tracking inventory to enable departments to order and manage inventory more efficiently and reduce waste

VistaTrak features a touch-screen interface and is available in two different sizes to address varying usage needs.


Related Content

News | Radiology Business

July 9, 2024 — Bracco and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time July 09, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Breast Imaging

March 8, 2024 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...

Time March 08, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
Feature | Contrast Media Injectors | By Christine Book

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in ...

Time January 17, 2024
arrow
News | Contrast Media

December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions ...

Time December 11, 2023
arrow
News | Interventional Radiology

November 3, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

Time November 03, 2023
arrow
Subscribe Now